SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?


To: tom pope who wrote (10410)2/12/2004 10:21:35 AM
From: Ian@SI  Read Replies (1) | Respond to of 52153
 
Yes, precisely. With the current process, Accutane gets approved. Imagine what could get approved if less rigor was applied to safety and none to efficacy.

Sorry for not more clearly stating my thoughts.
Ian